Insider Trading activities of Uniqure N.v. (QURE)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Uniqure N.v. (QURE) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Uniqure N.v. since year 2005. Table 2 shows the detailed insider transactions of Uniqure N.v. since 2005. The reporting company's ticker symbol is QURE. The reporting company's CIK number is 1590560.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $13,507,132.
The total value of stock option exercises since 2005 is $610,310.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Uniqure N.v. (QURE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-09 0 $0 4,000 $189,040 4,000 $21,240
2019-08 0 $0 14,460 $838,231 0 $0
2019-07 0 $0 8,000 $570,744 0 $0
2019-06 0 $0 14,000 $999,970 0 $0
2019-05 0 $0 8,000 $467,176 0 $0
2019-04 0 $0 7,546 $447,440 0 $0
2019-03 0 $0 67,376 $4,330,069 0 $0
2019-02 0 $0 8,000 $289,600 20,000 $106,199
2019-01 0 $0 44,064 $1,357,664 0 $0
2018-12 0 $0 5,000 $151,950 0 $0
2018-06 0 $0 23,929 $888,723 0 $0
2018-03 0 $0 39,169 $850,750 0 $0
2018-01 0 $0 65,534 $1,279,743 0 $0
2017-06 0 $0 115,230 $692,738 115,230 $399,081
2017-03 0 $0 25,422 $153,294 25,422 $83,790

Table 2. Detailed insider stock purchases, sales, and option exercises of Uniqure N.v. insiders (QURE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-09-16 Kuta Alexander Edward Iii (Executive VP, Operations) Sale 4,000 47.26 189,040
2019-09-16 Kuta Alexander Edward Iii (Executive VP, Operations) Option Ex 4,000 5.31 21,240
2019-08-21 Kapusta Matthew C (CEO, CFO, Managing Director) Sale 8,000 56.48 451,840
2019-08-01 Astley-sparke Philip (Director) Sale 6,460 59.81 386,391
2019-07-17 Kapusta Matthew C (CEO, CFO, Managing Director) Sale 8,000 71.34 570,744
2019-06-19 Kapusta Matthew C (CEO, CFO, Managing Director) Sale 8,000 77.61 620,920
2019-06-03 Astley-sparke Philip (Director) Sale 6,000 63.17 379,050
2019-05-15 Kapusta Matthew C (CEO, CFO, Managing Director) Sale 8,000 58.40 467,176
2019-04-16 Klemt Christian (Chief Accounting Officer) Sale 1,546 57.18 88,400
2019-04-01 Astley-sparke Philip (Director) Sale 6,000 59.84 359,040
2019-03-14 Kapusta Matthew C (CEO, CFO, Managing Director) Sale 19,688 63.52 1,250,522
2019-03-13 Kapusta Matthew C (CEO, CFO, Managing Director) Sale 47,688 64.58 3,079,547
2019-02-15 Kuta Alexander Edward Iii (SVP, Regulatory Affairs) Sale 8,000 36.20 289,600
2019-02-15 Kuta Alexander Edward Iii (SVP, Regulatory Affairs) Option Ex 20,000 5.31 106,199
2019-01-28 Springhorn Jeremy P. (Director) Sale 1,210 31.32 37,897
2019-01-28 Mcmillan Scott T. (Chief Operating Officer) Sale 591 31.23 18,456
2019-01-28 Klemt Christian (Chief Accounting Officer) Sale 1,479 31.29 46,277
2019-01-28 Kuta Alexander Edward Iii (SVP, Regulatory Affairs) Sale 1,052 31.29 32,917
2019-01-28 Schaffer David (Director) Sale 1,210 31.31 37,885
2019-01-28 Soteropoulos Paula (Director) Sale 1,210 31.32 37,897
2019-01-28 Balachandran Madhavan (Director) Sale 1,210 31.31 37,885
2019-01-28 Van Deventer Sander (Chief Scientific Officer) Sale 1,358 31.31 42,518
2019-01-28 Kapusta Matthew C (CEO, CFO, Managing Director) Sale 19,085 31.42 599,650
2019-01-28 Astley-sparke Philip (Director) Sale 1,210 31.32 37,897
2019-01-28 Kaye Jack (Director) Sale 1,210 31.31 37,885
2019-01-17 Schaffer David (Director) Sale 7,500 30.71 230,325
2019-01-03 Klemt Christian (Chief Accounting Officer) Sale 5,739 27.91 160,175
2018-12-03 Astley-sparke Philip (Director) Sale 5,000 30.39 151,950
2018-06-06 Zelenkofske Steven (Chief Medical Officer) Sale 23,929 37.14 888,723
2018-03-15 Kapusta Matthew C (CEO, CFO, Managing Director) Sale 39,169 21.72 850,750
2018-01-29 Schaffer David (Director) Sale 2,878 18.53 53,329
2018-01-29 Soteropoulos Paula (Director) Sale 2,878 18.53 53,329
2018-01-29 Van Deventer Sander (Chief Scientific Officer) Sale 5,985 18.53 110,902
2018-01-29 Astley-sparke Philip (Director) Sale 6,540 18.53 121,186
2018-01-29 Kaye Jack (Director) Sale 2,878 18.53 53,329
2018-01-04 Kapusta Matthew C (CEO, CFO, Managing Director) Sale 21,690 19.87 431,067
2018-01-03 Klemt Christian (Chief Accounting Officer) Sale 5,093 20.13 102,511
2018-01-03 Garen Jonathan (Chief Business Officer) Sale 5,864 20.13 118,030
2018-01-03 Firuta Paul E (Chief Commercial Officer) Sale 5,864 20.13 118,030
2018-01-03 Cantor Maria E (SVP, Investor Relations & Comm) Sale 5,864 20.13 118,030
2017-06-29 Petry Harald (Chief Scientific Officer) Sale 21,547 6.02 129,712
2017-06-29 Petry Harald (Chief Scientific Officer) Option Ex 21,547 3.50 75,436
2017-06-28 Petry Harald (Chief Scientific Officer) Sale 27,753 6.01 166,851
2017-06-28 Petry Harald (Chief Scientific Officer) Option Ex 27,753 3.49 96,941
2017-06-27 Petry Harald (Chief Scientific Officer) Sale 7,700 6.00 46,215
2017-06-27 Petry Harald (Chief Scientific Officer) Option Ex 7,700 3.48 26,803
2017-06-26 Petry Harald (Chief Scientific Officer) Sale 58,075 6.01 349,030
2017-06-26 Petry Harald (Chief Scientific Officer) Option Ex 58,075 3.43 199,371
2017-06-22 Petry Harald (Chief Scientific Officer) Sale 155 6.00 930
2017-06-22 Petry Harald (Chief Scientific Officer) Option Ex 155 3.42 530
2017-03-21 Petry Harald (Chief Scientific Officer) Sale 25,422 6.03 153,294
2017-03-21 Petry Harald (Chief Scientific Officer) Option Ex 25,422 3.30 83,790

Insider trading activities including stock purchases, stock sales, and option exercises of QURE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Uniqure N.v. (symbol QURE, CIK number 1590560) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month